SpringerLink
Log in

The Intersection of Anoikis Resistance and Fatty Acid Metabolism in Cancer

  • Chapter
  • First Online:
Anoikis

  • 333 Accesses

Abstract

Anoikis resistance is an essential adaption of cancer cells to metastasize effectively. Normally, the detachment of epithelial cells from the extracellular matrix induces cellular stressors, including nutrient-deprivation and oxidative stress, and this elevated cellular stress leads to apoptosis. In contrast, cancer cells often have an increased capacity to adapt to cellular stressors, and these adaptations include metabolic reprogramming to account for the changing nutrient microenvironment. Thus, metabolic plasticity and anoikis resistance cooperate to promote disease progression. For instance, high grade serous ovarian carcinoma, when disseminating with the peritoneal cavity, must resist anoikis to colonize distant sites, and these sites are often fat-rich environments. Consistently, a whole genome-wide screen in ovarian cancer cells uncovered and reinforced the hypothesis that cancer cells enhance fatty acid oxidation activity to avoid anoikis and successfully colonize a secondary site. Targeting metabolic reprogramming and fatty acid oxidation is a feasible approach to inhibit cancer progression. Emphasizing ovarian cancer as a model system, this chapter will focus on the metabolic pathway, fatty acid oxidation, as a means of overcoming nutrient-deprivation induced stress to promote anoikis resistance. Further, the chapter will focus on the pathways involved in fatty acid oxidation regulation and strategies to attenuate metabolic plasticity and promote anoikis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 106.99
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 139.09
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersen CL, Sikora MJ, Boisen MM, Ma T, Christie A, Tseng G, Park Y, Luthra S, Chandran U, Haluska P, Mantia-Smaldone GM, Odunsi K, McLean K, Lee AV, Elishaev E, Edwards RP, Oesterreich S (2017) Active estrogen receptor-alpha signaling in ovarian cancer models and clinical specimens. Clin Cancer Res 23:3802–3812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D’Amato NC, Elias A, Richer JK (2017) Androgen receptor supports an anchorage-independent, cancer stem cell-like population in triple-negative breast cancer. Cancer Res 77:3455–3466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Basak NP, Roy A, Banerjee S (2014) Alteration of mitochondrial proteome due to activation of Notch1 signaling pathway. J Biol Chem 289:7320–7334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bhatia V, Mula RV, Weigel NL, Falzon M (2009) Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res 7:1119–1131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bian Y, Yu Y, Wang S, Li L (2015) Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer. Biochem Biophys Res Commun 463:612–617

    Article  CAS  PubMed  Google Scholar 

  6. Blaskovich MA, Yendluri V, Lawrence HR, Lawrence NJ, Sebti SM, Springett GM (2013) Lysophosphatidic acid acyltransferase beta regulates mTOR signaling. PLoS ONE 8:

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Brown CW, Brodsky AS, Freiman RN (2015) Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. Mol Cancer Res 13:78–85

    Article  CAS  PubMed  Google Scholar 

  8. Casciano JC, Perry C, Cohen-Nowak AJ, Miller KD, Vande Voorde J, Zhang Q, Chalmers S, Sandison ME, Liu Q, Hedley A, Mcbryan T, Tang HY, Gorman N, Beer T, Speicher DW, Adams PD, Liu X, Schlegel R, Mccarron JG, Wakelam MJO, Gottlieb E, Kossenkov AV, Schug ZT (2020) MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer. Br J Cancer 122:868–884

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chanda D, Li J, Oligschlaeger Y, Jeurissen ML, Houben T, Walenbergh SM, Shiri-Sverdlov R, Neumann D (2016) MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. Exp Mol Med 48:e258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chang MY, Huang DY, Ho FM, Huang KC, Lin WW (2012) PKC-dependent human monocyte adhesion requires AMPK and Syk activation. PLoS ONE 7:e40999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen Z, Wang GX, Ma SL, Jung DY, Ha H, Altamimi T, Zhao XY, Guo L, Zhang P, Hu CR, Cheng JX, Lopaschuk GD, Kim JK, Lin JD (2017) Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Mol Metab 6:863–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. de Francesco EM, Maggiolini M, Tanowitz HB, Sotgia F, Lisanti MP (2017) Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for optimizing anti-angiogenic therapy. Oncotarget 8:56126–56142

    Article  PubMed  PubMed Central  Google Scholar 

  13. Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Butzow R, Coukos G, Zhang L (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 5:e10277

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Dey S, Sayers CM, Verginadis II, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA, Koumenis C (2015) ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest 125:2592–2608

    Article  PubMed  PubMed Central  Google Scholar 

  15. Douville J, Beaulieu R, Balicki D (2009) ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18:17–25

    Article  CAS  PubMed  Google Scholar 

  16. Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pages JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S (2014) Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer 13:264

    Google Scholar 

  17. Du S, Miao J, Zhu Z, Xu E, Shi L, Ai S, Wang F, Kang X, Chen H, Lu X, Guan W, **a X (2018) NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death Dis 9:948

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Feng WW, Kurokawa M (2020) Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer. Cancer Drug Resist 3

    Google Scholar 

  19. Fisher FM, Estall JL, Adams AC, Antonellis PJ, Bina HA, Flier JS, Kharitonenkov A, Spiegelman BM, Maratos-Flier E (2011) Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology 152:2996–3004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Flaig TW, Salzmann-Sullivan M, Su LJ, Zhang Z, Joshi M, Gijon MA, Kim J, Arcaroli JJ, van Bokhoven A, Lucia MS, la Rosa FG, Schlaepfer IR (2017) Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade. Oncotarget 8:56051–56065

    Article  PubMed  PubMed Central  Google Scholar 

  21. Folmes CD, Terzic A (2016) Energy metabolism in the acquisition and maintenance of stemness. Semin Cell Dev Biol 52:68–75

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619–626

    Article  CAS  PubMed  Google Scholar 

  23. Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly KLSE, Sood AK (2018) FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat Commun 9:2923

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Gower BA, Nagy TR, Blaylock ML, Wang C, Nyman L (2002) Estradiol may limit lipid oxidation via Cpt 1 expression and hormonal mechanisms. Obes Res 10:167–172

    Article  CAS  PubMed  Google Scholar 

  25. Grunt TW, Wagner R, Grusch M, Berger W, Singer CF, Marian B, Zielinski CC, Lupu R (2009) Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells. Biochem Biophys Res Commun 385:454–459

    Article  CAS  PubMed  Google Scholar 

  26. Guadamillas MC, Cerezo A, del Pozo MA (2011) Overcoming anoikis–pathways to anchorage-independent growth in cancer. J Cell Sci 124:3189–3197

    Article  CAS  PubMed  Google Scholar 

  27. Guo C, Xu LF, Li HM, Wang W, Guo JH, Jia MQ, Jia R, Jia J (2019) Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma. Peer J 7:e6978

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto AJ, Reginato MJ (2010) ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci 123:1373–1382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  30. Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL (2014) Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. J Biol Chem 289:23168–23176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Harrison H, Simoes BM, Rogerson L, Howell SJ, Landberg G, Clarke RB (2013) Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling. Breast Cancer Res 15:R21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Holubarsch CJ, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, Rhein S (2007) A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study. Clin Sci (Lond) 113:205–212

    Article  CAS  Google Scholar 

  33. Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, Crabtree J, Zabaleta J, Morello S, del Valle L, Burow M, Collins-Burow B, Pannuti A, Minter LM, Golde TE, Osborne BA, Miele L (2018) Notch signaling regulates mitochondrial metabolism and NF-kappaB activity in triple-negative breast cancer cells via IKKalpha-dependent non-canonical pathways. Front Oncol 8:575

    Article  PubMed  PubMed Central  Google Scholar 

  34. Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY, Chu YS, Matsumura N, Lai HC, Lee YF, Sim WJ, Chai C, Pietschmann E, Mori S, Low JJ, Choolani M, Thiery JP (2013) An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 4:e915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE, Schafer ZT, Evans RM, Suda T, Lee CH, Pandolfi PP (2012) A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med 18:1350–1358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Jabs M, Rose AJ, Lehmann LH, Taylor J, Moll I, Sijmonsma TP, Herberich SE, Sauer SW, Poschet G, Federico G, Mogler C, Weis EM, Augustin HG, Yan M, Gretz N, Schmid RM, Adams RH, Grone HJ, Hell R, Okun JG, Backs J, Nawroth PP, Herzig S, Fischer A (2018) Inhibition of endothelial notch signaling impairs fatty acid transport and leads to metabolic and vascular remodeling of the adult heart. Circulation 137:2592–2608

    Article  CAS  PubMed  Google Scholar 

  37. Jensen MD, Martin ML, Cryer PE, Roust LR (1994) Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 266:E914–E920

    CAS  PubMed  Google Scholar 

  38. Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485:661–665

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Jiang L, Wang H, Li J, Fang X, Pan H, Yuan X, Zhang P (2014) Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition. Int J Mol Sci 15:11539–11554

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Kamarajugadda S, Cai Q, Chen H, Nayak S, Zhu J, He M, ** Y, Zhang Y, Ai L, Martin SS, Tan M, Lu J (2013) Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death Dis 4:e504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Koundouros N, Poulogiannis G (2020) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122:4–22

    Article  CAS  PubMed  Google Scholar 

  42. Kwon OJ, Valdez JM, Zhang L, Zhang B, Wei X, Su Q, Ittmann MM, Creighton CJ, **n L (2014) Increased notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells. Nat Commun 5:4416

    Article  CAS  PubMed  Google Scholar 

  43. Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E (2018) Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37:2285–2301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Landor SK, Mutvei AP, Mamaeva V, ** S, Busk M, Borra R, Gronroos TJ, Kronqvist P, Lendahl U, Sahlgren CM (2011) Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc Natl Acad Sci U S A 108:18814–18819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Lee P, Rosen DG, Zhu C, Silva EG, Liu J (2005) Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol Oncol 96:671–677

    Article  CAS  PubMed  Google Scholar 

  46. Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ (2016) 17beta-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochem Biophys Res Commun 473:1247–1254

    Article  CAS  PubMed  Google Scholar 

  47. Lee SY, Long F (2018) Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J Clin Invest 128:5573–5586

    Article  PubMed  PubMed Central  Google Scholar 

  48. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204:2935–2948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Lim HJ, Lee S, Lee KS, Park JH, Jang Y, Lee EJ, Park HY (2006) PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. Prostaglandins Other Lipid Mediat 80:165–174

    Article  CAS  PubMed  Google Scholar 

  50. Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, Cao D (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283:3418–3423

    Article  CAS  PubMed  Google Scholar 

  51. Massard C, Azaro A, Soria JC, Lassen U, le Tourneau C, Sarker D, Smith C, Ohnmacht U, Oakley G, Patel BKR, Yuen ESM, Benhadji KA, Rodon J (2018) First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. Ann Oncol 29:1911–1917

    Article  CAS  PubMed  Google Scholar 

  52. Masuda T, Wada K, Nakajima A, Okura M, Kudo C, Kadowaki T, Kogo M, Kamisaki Y (2005) Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma. Clin Cancer Res 11:4012–4021

    Article  CAS  PubMed  Google Scholar 

  53. Menon D, Salloum D, Bernfeld E, Gorodetsky E, Akselrod A, Frias MA, Sudderth J, Chen PH, Deberardinis R, Foster DA (2017) Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid. J Biol Chem 292:6303–6311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Meredith Jr JE, Fazeli B, Schwartz MA (1993) The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953–961

    Article  CAS  Google Scholar 

  55. Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S (2012) Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer 19:R255–R279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Mossmann D, Park S, Hall MN (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer 18:744–757

    Article  CAS  PubMed  Google Scholar 

  57. Ng TL, Leprivier G, Robertson MD, Chow C, Martin MJ, Laderoute KR, Davicioni E, Triche TJ, Sorensen PH (2012) The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ 19:501–510

    Article  CAS  PubMed  Google Scholar 

  58. O’Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, Kam Y, Philipson B, Trefely S, Nunez-Cruz S, Blair IA, June CH, Milone MC (2018) The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep 8:6289

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Paoli P, Giannoni E, Chiarugi P (2013) Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 1833:3481–3498

    Article  CAS  PubMed  Google Scholar 

  60. Ruggiero CF, Malpicci D, Fattore L, Madonna G, Vanella V, Mallardo D, Liguoro D, Salvati V, Capone M, Bedogni B, Ascierto PA, Mancini R, Ciliberto G (2019) ErbB3 phosphorylation as central event in adaptive resistance to targeted therapy in metastatic melanoma: early detection in CTCs during therapy and insights into regulation by autocrine neuregulin. Cancers (Basel) 11

    Google Scholar 

  61. Sawyer BT, Qamar L, Yamamoto TM, Mcmellen A, Watson ZL, Richer JK, Behbakht K, Schlaepfer IR, Bitler BG (2020) Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression. Mol Cancer Res

    Google Scholar 

  62. Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ (2005) Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells. Cancer Res 65:2251–2259

    Article  CAS  PubMed  Google Scholar 

  63. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461:109–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Shao H, Mohamed EM, Xu GG, Waters M, **g K, Ma Y, Zhang Y, Spiegel S, Idowu MO, Fang X (2016) Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer. Oncotarget 7:3832–3846

    Article  PubMed  Google Scholar 

  65. Shen CJ, Chan SH, Lee CT, Huang WC, Tsai JP, Chen BK (2017) Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin. Cancer Lett 386:110–122

    Article  CAS  PubMed  Google Scholar 

  66. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71:3991–4001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Song S, Attia RR, Connaughton S, Niesen MI, Ness GC, Elam MB, Hori RT, Cook GA, Park EA (2010) Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements. Mol Cell Endocrinol 325:54–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Spector NL, Yarden Y, Smith B, Lyass L, Trusk P, Pry K, Hill JE, **a W, Seger R, Bacus SS (2007) Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proc Natl Acad Sci USA 104:10607–10612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. van Weverwijk A, Koundouros N, Iravani M, Ashenden M, Gao Q, Poulogiannis G, Jungwirth U, Isacke CM (2019) Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation. Nat Commun 10:2698

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Vella S, Penna I, Longo L, Pioggia G, Garbati P, Florio T, Rossi F, Pagano A (2015) Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA. Sci Rep 5:18144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC (2007) A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol Exp Ther 321:213–220

    Article  CAS  PubMed  Google Scholar 

  72. Wang Y, Lu JH, Wang F, Wang YN, He MM, Wu QN, Lu YX, Yu HE, Chen ZH, Zhao Q, Liu J, Chen YX, Wang DS, Sheng H, Liu ZX, Zeng ZL, Xu RH, Ju HQ (2020) Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Cancer Lett 473:74–89

    Article  CAS  PubMed  Google Scholar 

  73. Warburg O (1925) The metabolism of carcinoma cells. J Cancer Res

    Google Scholar 

  74. Wheeler LJ, Watson ZL, Qamar L, Yamamoto TM, Post MD, Berning AA, Spillman MA, Behbakht K, Bitler BG (2018) CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis 7:92

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Wheeler LJ, Watson ZL, Qamar L, Yamamoto TM, Sawyer BT, Sullivan KD, Khanal S, Joshi M, Ferchaud-Roucher V, Smith H, Vanderlinden LA, Brubaker SW, Caino CM, Kim H, Espinosa JM, Richer JK, Bitler BG (2019) Multi-omic approaches identify metabolic and autophagy regulators important in ovarian cancer dissemination. Science 19:474–491

    Google Scholar 

  76. **e M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, Zhao LP, Tian Y (2012) Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem 113:1501–1513

    CAS  PubMed  Google Scholar 

  77. **e Z, Dong Y, Scholz R, Neumann D, Zou MH (2008) Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 117:952–962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Yang C, Wang C, Ye M, ** C, He W, Wang F, McKeehan WL, Luo Y (2012) Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress. Nutr Metab (Lond) 9:94

    Article  CAS  Google Scholar 

  79. Ye M, Lu W, Wang X, Wang C, Abbruzzese JL, Liang G, Li X, Luo Y (2016) FGF21-FGFR1 coordinates phospholipid homeostasis, lipid droplet function, and ER stress in obesity. Endocrinology 157:4754–4769

    Article  CAS  PubMed  Google Scholar 

  80. Yin G, Liang Y, Wang Y, Yang Y, Yang M, Cen XM, **e QB (2017) mTOR complex 1 signalling regulates the balance between lipid synthesis and oxidation in hypoxia lymphocytes. Biosci Rep 37

    Google Scholar 

  81. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB (2006) Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55:2562–2570

    Article  CAS  PubMed  Google Scholar 

  82. Zacharowski K, Blackburn B, Thiemermann C (2001) Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol 418:105–110

    Article  CAS  PubMed  Google Scholar 

  83. Zhang GY, Ahmed N, Riley C, Oliva K, Barker G, Quinn MA, Rice GE (2005) Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer 92:113–119

    Article  CAS  PubMed  Google Scholar 

  84. Zhang YK, Qu YY, Lin Y, Wu XH, Chen HZ, Wang X, Zhou KQ, Wei Y, Guo F, Yao CF, He XD, Liu LX, Yang C, Guan ZY, Wang SD, Zhao J, Liu DP, Zhao SM, Xu W (2017) Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. Nat Commun 8:464

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  85. Zhao M, Jung Y, Jiang Z, Svensson KJ (2020) Regulation of energy metabolism by receptor tyrosine kinase ligands. Front Physiol 11:354

    Article  PubMed  PubMed Central  Google Scholar 

  86. Zheng J, Zhou J, **e X, **e B, Lin J, Xu Z, Zhang W (2014) Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1. DNA Cell Biol 33:847–853

    Article  CAS  PubMed  Google Scholar 

  87. Zhu G, Xu P, Guo S, Yi X, Wang H, Yang Y, Liu L, Shi Q, Gao T, Li C (2020) Metastatic melanoma cells rely on sestrin2 to acquire anoikis resistance via detoxifying intracellular ROS. J Invest Dermatol 140(666–675):e2

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Biology Graduate Program, The University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA

    Jaidev Bapat

  2. Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA

    Jaidev Bapat & Benjamin G. Bitler

  3. Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, 12700 E. 19th Ave, MS 8613, Aurora, CO, 80045, USA

    Benjamin G. Bitler

Authors
  1. Jaidev Bapat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin G. Bitler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin G. Bitler .

Editor information

Editors and Affiliations

  1. WVU Cancer Institute and Department of Biochemistry, West Virginia University, Morgantown, WV, USA

    Steven M. Frisch

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bapat, J., Bitler, B.G. (2021). The Intersection of Anoikis Resistance and Fatty Acid Metabolism in Cancer. In: Frisch, S.M. (eds) Anoikis. Springer, Cham. https://doi.org/10.1007/978-3-030-73856-3_3

Download citation

Publish with us

Policies and ethics

Search

Navigation